Previous 10 | Next 10 |
2024-05-08 17:35:54 ET More on Health Catalyst Health Catalyst: Achieving FY28 Long-Term Guidance Is Possible Health Catalyst, Inc. (HCAT) Q4 2023 Earnings Call Transcript Health Catalyst Looks To Slim Down As It Faces Industry Headwinds (Downgrade) R1 RCM, H...
SALT LAKE CITY, April 24, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its first quarter 2024 operating results on Thursday, May 9, 2024, after market cl...
2024-04-12 17:05:37 ET Gainers: Applied Optoelectronics ( AAOI ) +5% . Eliem Therapeutics ( ELYM ) +4% . Infinera Corporation ( INFN ) +4% . Harrow ( HROW ) +4% . Health Catalyst ( HCAT ) +4% . Losers: Eagle Pharmaceutica...
2024-04-12 02:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-04-10 12:56:01 ET More on Certara, GoodRx Holdings, etc. GoodRx Holdings: Large TAM Continues To Support Growth Health Catalyst: Achieving FY28 Long-Term Guidance Is Possible Voss Capital - R1 RCM Inc.: Bull Case Achievable Despite Negative Sentiment Wel...
2024-04-10 06:15:02 ET KeyBanc analyst issues SECTOR WEIGHT recommendation for HCAT on April 10, 2024 04:37AM ET. The previous analyst recommendation was Overweight. HCAT was trading at $6.68 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...
2024-03-23 03:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-03-09 04:50:41 ET Summary Health Catalyst reported strong Q4 results, meeting guidance and showing growth in technology and professional services revenue. The drop in HCAT's share price presents a buying opportunity, as the company's growth initiatives, such as its TEMS offer...
2024-03-02 11:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Health Catalyst Names UnityPoint Health Winner of the 2024 Flywheel Award PR Newswire SALT LAKE CITY , Feb. 27, 2024 /PRNewswire/ -- Today, Health Catalyst announced the winner of the 2024 Flywheel Award. The award recognizes healthcare organizations that have sh...
News, Short Squeeze, Breakout and More Instantly...
Health Catalyst Inc Company Name:
HCAT Stock Symbol:
NYSE Market:
Wall Street has been hovering around a record high level, which can trigger overvaluation concerns in some investors' minds. This is because in...
Health Catalyst Acquires Oncology-Focused Health Technology Company Carevive PR Newswire SALT LAKE CITY , June 6, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services t...
2024-05-21 18:30:04 ET Raymond James analyst issues UNDERPERFORM recommendation for HCAT on May 21, 2024 04:00PM ET. The previous analyst recommendation was Underperform. HCAT was trading at $6.77 at issue of the analyst recommendation. The overall analyst consensus : BU...